nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—Omeprazole—Barrett's esophagus	0.123	0.515	CbGbCtD
Captopril—CYP2D6—Omeprazole—Barrett's esophagus	0.116	0.485	CbGbCtD
Captopril—LTA4H—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.0368	0.182	CbGpPWpGaD
Captopril—LTA4H—exocrine gland—Barrett's esophagus	0.0273	0.143	CbGeAlD
Captopril—REN—exocrine gland—Barrett's esophagus	0.0211	0.11	CbGeAlD
Captopril—LTA4H—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.0205	0.101	CbGpPWpGaD
Captopril—MMP2—exocrine gland—Barrett's esophagus	0.0194	0.101	CbGeAlD
Captopril—LTA4H—smooth muscle tissue—Barrett's esophagus	0.0115	0.0598	CbGeAlD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0106	0.0523	CbGpPWpGaD
Captopril—REN—Peptide hormone metabolism—CDX2—Barrett's esophagus	0.00988	0.0489	CbGpPWpGaD
Captopril—REN—epithelium—Barrett's esophagus	0.00918	0.0479	CbGeAlD
Captopril—LTA4H—digestive system—Barrett's esophagus	0.00904	0.0472	CbGeAlD
Captopril—REN—smooth muscle tissue—Barrett's esophagus	0.00884	0.0461	CbGeAlD
Captopril—MMP2—epithelium—Barrett's esophagus	0.00843	0.044	CbGeAlD
Captopril—MMP2—smooth muscle tissue—Barrett's esophagus	0.00813	0.0424	CbGeAlD
Captopril—Nephrotic syndrome—Esomeprazole—Barrett's esophagus	0.00778	0.0211	CcSEcCtD
Captopril—Nephrotic syndrome—Omeprazole—Barrett's esophagus	0.00778	0.0211	CcSEcCtD
Captopril—MMP9—epithelium—Barrett's esophagus	0.00734	0.0383	CbGeAlD
Captopril—LTA4H—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.00722	0.0357	CbGpPWpGaD
Captopril—MMP9—smooth muscle tissue—Barrett's esophagus	0.00707	0.0369	CbGeAlD
Captopril—REN—digestive system—Barrett's esophagus	0.00698	0.0364	CbGeAlD
Captopril—Hepatic necrosis—Omeprazole—Barrett's esophagus	0.00647	0.0176	CcSEcCtD
Captopril—Hepatic necrosis—Esomeprazole—Barrett's esophagus	0.00647	0.0176	CcSEcCtD
Captopril—MMP2—digestive system—Barrett's esophagus	0.00642	0.0335	CbGeAlD
Captopril—F2—epithelium—Barrett's esophagus	0.0064	0.0334	CbGeAlD
Captopril—Laryngeal oedema—Esomeprazole—Barrett's esophagus	0.00586	0.0159	CcSEcCtD
Captopril—Laryngeal oedema—Omeprazole—Barrett's esophagus	0.00586	0.0159	CcSEcCtD
Captopril—MMP9—digestive system—Barrett's esophagus	0.00558	0.0291	CbGeAlD
Captopril—Nephritis interstitial—Esomeprazole—Barrett's esophagus	0.00557	0.0151	CcSEcCtD
Captopril—Nephritis interstitial—Omeprazole—Barrett's esophagus	0.00557	0.0151	CcSEcCtD
Captopril—SLC15A1—epithelium—Barrett's esophagus	0.00545	0.0285	CbGeAlD
Captopril—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00491	0.0133	CcSEcCtD
Captopril—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00491	0.0133	CcSEcCtD
Captopril—F2—digestive system—Barrett's esophagus	0.00487	0.0254	CbGeAlD
Captopril—Necrosis—Esomeprazole—Barrett's esophagus	0.00479	0.013	CcSEcCtD
Captopril—Necrosis—Omeprazole—Barrett's esophagus	0.00479	0.013	CcSEcCtD
Captopril—Ageusia—Omeprazole—Barrett's esophagus	0.00464	0.0126	CcSEcCtD
Captopril—Ageusia—Esomeprazole—Barrett's esophagus	0.00464	0.0126	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00461	0.0228	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—CDX2—Barrett's esophagus	0.00441	0.0218	CbGpPWpGaD
Captopril—Proteinuria—Omeprazole—Barrett's esophagus	0.00428	0.0116	CcSEcCtD
Captopril—Proteinuria—Esomeprazole—Barrett's esophagus	0.00428	0.0116	CcSEcCtD
Captopril—Protein urine present—Omeprazole—Barrett's esophagus	0.00422	0.0115	CcSEcCtD
Captopril—Protein urine present—Esomeprazole—Barrett's esophagus	0.00422	0.0115	CcSEcCtD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.0042	0.0208	CbGpPWpGaD
Captopril—SLC15A1—digestive system—Barrett's esophagus	0.00415	0.0216	CbGeAlD
Captopril—Glossitis—Esomeprazole—Barrett's esophagus	0.00408	0.0111	CcSEcCtD
Captopril—Glossitis—Omeprazole—Barrett's esophagus	0.00408	0.0111	CcSEcCtD
Captopril—LTA4H—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00401	0.0199	CbGpPWpGaD
Captopril—ACE—epithelium—Barrett's esophagus	0.00391	0.0204	CbGeAlD
Captopril—ACE—smooth muscle tissue—Barrett's esophagus	0.00377	0.0197	CbGeAlD
Captopril—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.00376	0.0102	CcSEcCtD
Captopril—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00376	0.0102	CcSEcCtD
Captopril—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00376	0.0102	CcSEcCtD
Captopril—Blood pressure increased—Omeprazole—Barrett's esophagus	0.00376	0.0102	CcSEcCtD
Captopril—Dry eye—Omeprazole—Barrett's esophagus	0.00347	0.00944	CcSEcCtD
Captopril—Dry eye—Esomeprazole—Barrett's esophagus	0.00347	0.00944	CcSEcCtD
Captopril—Urine output increased—Esomeprazole—Barrett's esophagus	0.0034	0.00924	CcSEcCtD
Captopril—Urine output increased—Omeprazole—Barrett's esophagus	0.0034	0.00924	CcSEcCtD
Captopril—Gynaecomastia—Omeprazole—Barrett's esophagus	0.00336	0.00914	CcSEcCtD
Captopril—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.00336	0.00914	CcSEcCtD
Captopril—MMP9—Osteopontin Signaling—RELA—Barrett's esophagus	0.00328	0.0162	CbGpPWpGaD
Captopril—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.0032	0.00869	CcSEcCtD
Captopril—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.0032	0.00869	CcSEcCtD
Captopril—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00311	0.00845	CcSEcCtD
Captopril—Polyuria—Esomeprazole—Barrett's esophagus	0.00311	0.00845	CcSEcCtD
Captopril—Photosensitivity—Omeprazole—Barrett's esophagus	0.00311	0.00845	CcSEcCtD
Captopril—Polyuria—Omeprazole—Barrett's esophagus	0.00311	0.00845	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—MCL1—Barrett's esophagus	0.00306	0.0152	CbGpPWpGaD
Captopril—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00302	0.00822	CcSEcCtD
Captopril—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00302	0.00822	CcSEcCtD
Captopril—ACE—digestive system—Barrett's esophagus	0.00297	0.0155	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00292	0.0145	CbGpPWpGaD
Captopril—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00274	0.00745	CcSEcCtD
Captopril—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00274	0.00745	CcSEcCtD
Captopril—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00266	0.0132	CbGpPWpGaD
Captopril—MMP2—Osteopontin-mediated events—RELA—Barrett's esophagus	0.00249	0.0123	CbGpPWpGaD
Captopril—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00241	0.00654	CcSEcCtD
Captopril—Muscular weakness—Omeprazole—Barrett's esophagus	0.00241	0.00654	CcSEcCtD
Captopril—MMP9—Syndecan-1-mediated signaling events—HGF—Barrett's esophagus	0.00239	0.0118	CbGpPWpGaD
Captopril—Bronchospasm—Omeprazole—Barrett's esophagus	0.00232	0.00631	CcSEcCtD
Captopril—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00232	0.00631	CcSEcCtD
Captopril—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00231	0.00629	CcSEcCtD
Captopril—Pancreatitis—Omeprazole—Barrett's esophagus	0.00231	0.00629	CcSEcCtD
Captopril—Angina pectoris—Esomeprazole—Barrett's esophagus	0.0023	0.00625	CcSEcCtD
Captopril—Angina pectoris—Omeprazole—Barrett's esophagus	0.0023	0.00625	CcSEcCtD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.00225	0.0111	CbGpPWpGaD
Captopril—Pancytopenia—Omeprazole—Barrett's esophagus	0.00224	0.00609	CcSEcCtD
Captopril—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00224	0.00609	CcSEcCtD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—Barrett's esophagus	0.00221	0.0109	CbGpPWpGaD
Captopril—Neutropenia—Esomeprazole—Barrett's esophagus	0.00221	0.006	CcSEcCtD
Captopril—Neutropenia—Omeprazole—Barrett's esophagus	0.00221	0.006	CcSEcCtD
Captopril—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00218	0.00592	CcSEcCtD
Captopril—Pollakiuria—Omeprazole—Barrett's esophagus	0.00218	0.00592	CcSEcCtD
Captopril—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00217	0.00591	CcSEcCtD
Captopril—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00217	0.00591	CcSEcCtD
Captopril—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00215	0.00585	CcSEcCtD
Captopril—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00215	0.00585	CcSEcCtD
Captopril—Weight decreased—Omeprazole—Barrett's esophagus	0.00213	0.0058	CcSEcCtD
Captopril—Weight decreased—Esomeprazole—Barrett's esophagus	0.00213	0.0058	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00208	0.00567	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00208	0.00567	CcSEcCtD
Captopril—MMP2—Syndecan-2-mediated signaling events—CXCL8—Barrett's esophagus	0.00208	0.0103	CbGpPWpGaD
Captopril—Renal failure—Esomeprazole—Barrett's esophagus	0.00207	0.00562	CcSEcCtD
Captopril—Renal failure—Omeprazole—Barrett's esophagus	0.00207	0.00562	CcSEcCtD
Captopril—Stomatitis—Omeprazole—Barrett's esophagus	0.00205	0.00557	CcSEcCtD
Captopril—Jaundice—Esomeprazole—Barrett's esophagus	0.00205	0.00557	CcSEcCtD
Captopril—Jaundice—Omeprazole—Barrett's esophagus	0.00205	0.00557	CcSEcCtD
Captopril—Stomatitis—Esomeprazole—Barrett's esophagus	0.00205	0.00557	CcSEcCtD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.00204	0.0101	CbGpPWpGaD
Captopril—MMP2—FOXM1 transcription factor network—CDKN2A—Barrett's esophagus	0.00203	0.0101	CbGpPWpGaD
Captopril—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00196	0.00533	CcSEcCtD
Captopril—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00196	0.00533	CcSEcCtD
Captopril—Rhinitis—Omeprazole—Barrett's esophagus	0.00189	0.00514	CcSEcCtD
Captopril—Rhinitis—Esomeprazole—Barrett's esophagus	0.00189	0.00514	CcSEcCtD
Captopril—Hepatitis—Omeprazole—Barrett's esophagus	0.00189	0.00513	CcSEcCtD
Captopril—Hepatitis—Esomeprazole—Barrett's esophagus	0.00189	0.00513	CcSEcCtD
Captopril—Hallucination—Esomeprazole—Barrett's esophagus	0.00188	0.00511	CcSEcCtD
Captopril—Hallucination—Omeprazole—Barrett's esophagus	0.00188	0.00511	CcSEcCtD
Captopril—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00187	0.00509	CcSEcCtD
Captopril—Pharyngitis—Omeprazole—Barrett's esophagus	0.00187	0.00509	CcSEcCtD
Captopril—REN—Metabolism of proteins—CDX2—Barrett's esophagus	0.00187	0.00923	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—HGF—Barrett's esophagus	0.00181	0.00894	CbGpPWpGaD
Captopril—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00178	0.00485	CcSEcCtD
Captopril—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00178	0.00485	CcSEcCtD
Captopril—Flushing—Esomeprazole—Barrett's esophagus	0.00175	0.00476	CcSEcCtD
Captopril—Flushing—Omeprazole—Barrett's esophagus	0.00175	0.00476	CcSEcCtD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.0017	0.00841	CbGpPWpGaD
Captopril—Alopecia—Omeprazole—Barrett's esophagus	0.00167	0.00453	CcSEcCtD
Captopril—Alopecia—Esomeprazole—Barrett's esophagus	0.00167	0.00453	CcSEcCtD
Captopril—MMP9—Osteopontin-mediated events—RELA—Barrett's esophagus	0.00163	0.00809	CbGpPWpGaD
Captopril—Tension—Esomeprazole—Barrett's esophagus	0.00161	0.00438	CcSEcCtD
Captopril—Tension—Omeprazole—Barrett's esophagus	0.00161	0.00438	CcSEcCtD
Captopril—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00161	0.00437	CcSEcCtD
Captopril—Dysgeusia—Omeprazole—Barrett's esophagus	0.00161	0.00437	CcSEcCtD
Captopril—Nervousness—Omeprazole—Barrett's esophagus	0.0016	0.00434	CcSEcCtD
Captopril—Nervousness—Esomeprazole—Barrett's esophagus	0.0016	0.00434	CcSEcCtD
Captopril—Vision blurred—Esomeprazole—Barrett's esophagus	0.00155	0.00421	CcSEcCtD
Captopril—Vision blurred—Omeprazole—Barrett's esophagus	0.00155	0.00421	CcSEcCtD
Captopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00153	0.00757	CbGpPWpGaD
Captopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00153	0.00757	CbGpPWpGaD
Captopril—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00152	0.00415	CcSEcCtD
Captopril—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00152	0.00415	CcSEcCtD
Captopril—Anaemia—Omeprazole—Barrett's esophagus	0.00152	0.00413	CcSEcCtD
Captopril—Anaemia—Esomeprazole—Barrett's esophagus	0.00152	0.00413	CcSEcCtD
Captopril—Angioedema—Omeprazole—Barrett's esophagus	0.0015	0.00408	CcSEcCtD
Captopril—Angioedema—Esomeprazole—Barrett's esophagus	0.0015	0.00408	CcSEcCtD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.00149	0.00739	CbGpPWpGaD
Captopril—Malaise—Esomeprazole—Barrett's esophagus	0.00148	0.00403	CcSEcCtD
Captopril—Malaise—Omeprazole—Barrett's esophagus	0.00148	0.00403	CcSEcCtD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.00147	0.0073	CbGpPWpGaD
Captopril—CYP2D6—digestive system—Barrett's esophagus	0.00146	0.00759	CbGeAlD
Captopril—Palpitations—Omeprazole—Barrett's esophagus	0.00145	0.00395	CcSEcCtD
Captopril—Palpitations—Esomeprazole—Barrett's esophagus	0.00145	0.00395	CcSEcCtD
Captopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—Barrett's esophagus	0.00143	0.00709	CbGpPWpGaD
Captopril—Cough—Omeprazole—Barrett's esophagus	0.00143	0.0039	CcSEcCtD
Captopril—Cough—Esomeprazole—Barrett's esophagus	0.00143	0.0039	CcSEcCtD
Captopril—MMP2—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.0014	0.00694	CbGpPWpGaD
Captopril—Chest pain—Esomeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—Arthralgia—Esomeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—Myalgia—Omeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—Chest pain—Omeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—Myalgia—Esomeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—Arthralgia—Omeprazole—Barrett's esophagus	0.0014	0.0038	CcSEcCtD
Captopril—MMP2—LPA receptor mediated events—RELA—Barrett's esophagus	0.0014	0.00691	CbGpPWpGaD
Captopril—Discomfort—Omeprazole—Barrett's esophagus	0.00138	0.00376	CcSEcCtD
Captopril—Discomfort—Esomeprazole—Barrett's esophagus	0.00138	0.00376	CcSEcCtD
Captopril—ABCB1—epithelium—Barrett's esophagus	0.00138	0.00718	CbGeAlD
Captopril—Dry mouth—Esomeprazole—Barrett's esophagus	0.00137	0.00372	CcSEcCtD
Captopril—Dry mouth—Omeprazole—Barrett's esophagus	0.00137	0.00372	CcSEcCtD
Captopril—MMP2—AGE/RAGE pathway—RELA—Barrett's esophagus	0.00136	0.00674	CbGpPWpGaD
Captopril—Confusional state—Esomeprazole—Barrett's esophagus	0.00135	0.00368	CcSEcCtD
Captopril—Confusional state—Omeprazole—Barrett's esophagus	0.00135	0.00368	CcSEcCtD
Captopril—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00134	0.00365	CcSEcCtD
Captopril—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00134	0.00365	CcSEcCtD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.00134	0.00662	CbGpPWpGaD
Captopril—Shock—Esomeprazole—Barrett's esophagus	0.00132	0.00359	CcSEcCtD
Captopril—Shock—Omeprazole—Barrett's esophagus	0.00132	0.00359	CcSEcCtD
Captopril—MMP2—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.00132	0.00651	CbGpPWpGaD
Captopril—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00131	0.00357	CcSEcCtD
Captopril—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00131	0.00357	CcSEcCtD
Captopril—Tachycardia—Omeprazole—Barrett's esophagus	0.00131	0.00356	CcSEcCtD
Captopril—Tachycardia—Esomeprazole—Barrett's esophagus	0.00131	0.00356	CcSEcCtD
Captopril—LTA4H—Metabolism—PTGES—Barrett's esophagus	0.0013	0.00644	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—HGF—Barrett's esophagus	0.00129	0.00636	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.00128	0.00634	CbGpPWpGaD
Captopril—Anorexia—Omeprazole—Barrett's esophagus	0.00128	0.00348	CcSEcCtD
Captopril—Anorexia—Esomeprazole—Barrett's esophagus	0.00128	0.00348	CcSEcCtD
Captopril—MMP2—Extracellular matrix organization—BMP4—Barrett's esophagus	0.00128	0.00632	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00122	0.00332	CcSEcCtD
Captopril—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00122	0.00332	CcSEcCtD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.00121	0.006	CbGpPWpGaD
Captopril—Insomnia—Omeprazole—Barrett's esophagus	0.00121	0.0033	CcSEcCtD
Captopril—Insomnia—Esomeprazole—Barrett's esophagus	0.00121	0.0033	CcSEcCtD
Captopril—Paraesthesia—Omeprazole—Barrett's esophagus	0.0012	0.00327	CcSEcCtD
Captopril—Paraesthesia—Esomeprazole—Barrett's esophagus	0.0012	0.00327	CcSEcCtD
Captopril—Dyspnoea—Omeprazole—Barrett's esophagus	0.0012	0.00325	CcSEcCtD
Captopril—Dyspnoea—Esomeprazole—Barrett's esophagus	0.0012	0.00325	CcSEcCtD
Captopril—Somnolence—Esomeprazole—Barrett's esophagus	0.00119	0.00324	CcSEcCtD
Captopril—Somnolence—Omeprazole—Barrett's esophagus	0.00119	0.00324	CcSEcCtD
Captopril—Dyspepsia—Omeprazole—Barrett's esophagus	0.00118	0.00321	CcSEcCtD
Captopril—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00118	0.00321	CcSEcCtD
Captopril—Decreased appetite—Omeprazole—Barrett's esophagus	0.00117	0.00317	CcSEcCtD
Captopril—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00117	0.00317	CcSEcCtD
Captopril—Fatigue—Esomeprazole—Barrett's esophagus	0.00116	0.00314	CcSEcCtD
Captopril—Fatigue—Omeprazole—Barrett's esophagus	0.00116	0.00314	CcSEcCtD
Captopril—Constipation—Omeprazole—Barrett's esophagus	0.00115	0.00312	CcSEcCtD
Captopril—Constipation—Esomeprazole—Barrett's esophagus	0.00115	0.00312	CcSEcCtD
Captopril—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00111	0.003	CcSEcCtD
Captopril—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00111	0.003	CcSEcCtD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.0011	0.00544	CbGpPWpGaD
Captopril—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.0011	0.00298	CcSEcCtD
Captopril—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.0011	0.00298	CcSEcCtD
Captopril—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00106	0.00288	CcSEcCtD
Captopril—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00106	0.00288	CcSEcCtD
Captopril—Abdominal pain—Omeprazole—Barrett's esophagus	0.00106	0.00288	CcSEcCtD
Captopril—Body temperature increased—Omeprazole—Barrett's esophagus	0.00106	0.00288	CcSEcCtD
Captopril—F2—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00106	0.00523	CbGpPWpGaD
Captopril—ABCB1—digestive system—Barrett's esophagus	0.00105	0.00546	CbGeAlD
Captopril—LTA4H—Metabolism—CYP26A1—Barrett's esophagus	0.000987	0.00488	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000984	0.00487	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.00098	0.00485	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000973	0.00481	CbGpPWpGaD
Captopril—Asthenia—Esomeprazole—Barrett's esophagus	0.000962	0.00262	CcSEcCtD
Captopril—Asthenia—Omeprazole—Barrett's esophagus	0.000962	0.00262	CcSEcCtD
Captopril—MMP2—Direct p53 effectors—APC—Barrett's esophagus	0.000955	0.00472	CbGpPWpGaD
Captopril—Pruritus—Esomeprazole—Barrett's esophagus	0.000949	0.00258	CcSEcCtD
Captopril—Pruritus—Omeprazole—Barrett's esophagus	0.000949	0.00258	CcSEcCtD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000946	0.00468	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CDX2—Barrett's esophagus	0.000927	0.00459	CbGpPWpGaD
Captopril—Diarrhoea—Omeprazole—Barrett's esophagus	0.000918	0.00249	CcSEcCtD
Captopril—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000918	0.00249	CcSEcCtD
Captopril—MMP9—LPA receptor mediated events—RELA—Barrett's esophagus	0.000915	0.00453	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000915	0.00453	CbGpPWpGaD
Captopril—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000903	0.00447	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000893	0.00442	CbGpPWpGaD
Captopril—Dizziness—Esomeprazole—Barrett's esophagus	0.000887	0.00241	CcSEcCtD
Captopril—Dizziness—Omeprazole—Barrett's esophagus	0.000887	0.00241	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000886	0.00438	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000863	0.00427	CbGpPWpGaD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000861	0.00426	CbGpPWpGaD
Captopril—Vomiting—Esomeprazole—Barrett's esophagus	0.000853	0.00232	CcSEcCtD
Captopril—Vomiting—Omeprazole—Barrett's esophagus	0.000853	0.00232	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000848	0.00419	CbGpPWpGaD
Captopril—Rash—Omeprazole—Barrett's esophagus	0.000846	0.0023	CcSEcCtD
Captopril—Rash—Esomeprazole—Barrett's esophagus	0.000846	0.0023	CcSEcCtD
Captopril—Dermatitis—Esomeprazole—Barrett's esophagus	0.000845	0.0023	CcSEcCtD
Captopril—Dermatitis—Omeprazole—Barrett's esophagus	0.000845	0.0023	CcSEcCtD
Captopril—Headache—Esomeprazole—Barrett's esophagus	0.00084	0.00228	CcSEcCtD
Captopril—Headache—Omeprazole—Barrett's esophagus	0.00084	0.00228	CcSEcCtD
Captopril—MMP9—Extracellular matrix organization—BMP4—Barrett's esophagus	0.000838	0.00415	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CDX2—Barrett's esophagus	0.000834	0.00412	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000803	0.00397	CbGpPWpGaD
Captopril—Nausea—Esomeprazole—Barrett's esophagus	0.000797	0.00217	CcSEcCtD
Captopril—Nausea—Omeprazole—Barrett's esophagus	0.000797	0.00217	CcSEcCtD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000796	0.00394	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000742	0.00367	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000729	0.00361	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000722	0.00357	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000716	0.00354	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC9A1—Barrett's esophagus	0.000711	0.00352	CbGpPWpGaD
Captopril—F2—Folate Metabolism—RELA—Barrett's esophagus	0.00069	0.00341	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000641	0.00317	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000574	0.00284	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000548	0.00271	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000545	0.0027	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000532	0.00263	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000531	0.00263	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000529	0.00262	CbGpPWpGaD
Captopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000503	0.00249	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000493	0.00244	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00048	0.00238	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000476	0.00235	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CDX2—Barrett's esophagus	0.000469	0.00232	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.00046	0.00228	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000452	0.00224	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—Barrett's esophagus	0.000447	0.00221	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—Barrett's esophagus	0.000431	0.00213	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.000404	0.002	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—Barrett's esophagus	0.000399	0.00197	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000398	0.00197	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000394	0.00195	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000394	0.00195	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000389	0.00192	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000385	0.00191	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—SST—Barrett's esophagus	0.000366	0.00181	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000336	0.00166	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—PPARG—Barrett's esophagus	0.000336	0.00166	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000326	0.00161	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PPARG—Barrett's esophagus	0.000325	0.00161	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—Barrett's esophagus	0.000325	0.00161	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GAST—Barrett's esophagus	0.000302	0.00149	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000279	0.00138	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GAST—Barrett's esophagus	0.000274	0.00135	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000274	0.00135	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—RELA—Barrett's esophagus	0.000272	0.00135	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—Barrett's esophagus	0.000255	0.00126	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000247	0.00122	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000242	0.0012	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000242	0.0012	CbGpPWpGaD
Captopril—F2—Hemostasis—HGF—Barrett's esophagus	0.000233	0.00115	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—PPARG—Barrett's esophagus	0.00022	0.00109	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000217	0.00108	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000211	0.00105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GAST—Barrett's esophagus	0.000209	0.00104	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—SST—Barrett's esophagus	0.000207	0.00102	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000205	0.00101	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000198	0.000979	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000196	0.000968	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—SST—Barrett's esophagus	0.000188	0.000929	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000187	0.000926	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00018	0.000889	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000179	0.000887	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—RELA—Barrett's esophagus	0.000178	0.000883	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CXCL8—Barrett's esophagus	0.000178	0.00088	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GAST—Barrett's esophagus	0.000162	0.0008	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—Barrett's esophagus	0.000158	0.000783	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SST—Barrett's esophagus	0.000144	0.00071	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000142	0.000705	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000131	0.000649	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000126	0.000622	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SST—Barrett's esophagus	0.000111	0.000549	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.00011	0.000545	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGES—Barrett's esophagus	0.000108	0.000533	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CXCL8—Barrett's esophagus	0.0001	0.000496	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9.96e-05	0.000493	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGES—Barrett's esophagus	9.44e-05	0.000467	CbGpPWpGaD
Captopril—ALB—Hemostasis—HGF—Barrett's esophagus	9.25e-05	0.000457	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGES—Barrett's esophagus	8.89e-05	0.00044	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP26A1—Barrett's esophagus	8.16e-05	0.000404	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL8—Barrett's esophagus	8.05e-05	0.000398	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—Barrett's esophagus	7.82e-05	0.000387	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—Barrett's esophagus	7.6e-05	0.000376	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL8—Barrett's esophagus	7.31e-05	0.000362	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	7.15e-05	0.000354	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	6.74e-05	0.000334	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.03e-05	0.000298	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—Barrett's esophagus	5.94e-05	0.000294	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.93e-05	0.000293	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC9A1—Barrett's esophagus	5.88e-05	0.000291	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—Barrett's esophagus	5.87e-05	0.00029	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL8—Barrett's esophagus	5.59e-05	0.000277	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	5.16e-05	0.000255	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	4.86e-05	0.00024	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.75e-05	0.000235	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—Barrett's esophagus	4.58e-05	0.000227	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL8—Barrett's esophagus	4.32e-05	0.000214	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—Barrett's esophagus	3.43e-05	0.00017	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—Barrett's esophagus	3.1e-05	0.000153	CbGpPWpGaD
Captopril—ALB—Metabolism—PPARG—Barrett's esophagus	2.69e-05	0.000133	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—Barrett's esophagus	2.65e-05	0.000131	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPARG—Barrett's esophagus	2.35e-05	0.000116	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPARG—Barrett's esophagus	2.22e-05	0.00011	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—Barrett's esophagus	2.11e-05	0.000105	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.85e-05	9.16e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	1.74e-05	8.63e-05	CbGpPWpGaD
